Hagop Youssoufian, MDEnriched profile
Chief Medical Advisor, Kojin Therapeutics; Founder and Principal, Youssoufian Consulting, LLC · Youssoufian Consulting, LLC (Founder/Principal) and Kojin Therapeutics (Chief Medical Advisor)
Overview
Updated 14 Jul 2026
Hagop Youssoufian, MD, is Chief Medical Advisor, Kojin Therapeutics at Youssoufian Consulting, LLC (Founder/Principal) and Kojin Therapeutics (Chief Medical Advisor). The public record shows 295 publications with 17,129 citations (h-index 51), centered on Leukemia (AML/ALL/CML/CLL), Pancreatic Cancer, Colorectal Cancer. It also documents an investigator role on 25 registered clinical trials, industry payments reported by 1 companies.
- Top research focus: Leukemia (AML/ALL/CML/CLL)
- 25 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:
- Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
Sponsor: Treos Bio Limited
InvestigatorPhase 2Active, not recruitingNCT05243862 - Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer
Sponsor: Verastem, Inc.
InvestigatorPhase 1TerminatedNCT02943317 - A Phase I, Open-label Study of Absorption, Metabolism, and Excretion of Defactinib (VS-6063) in Healthy Male Subjects
Sponsor: Verastem, Inc.
InvestigatorPhase 1CompletedNCT02913716
Industry payments
Updated 14 Jul 2026
1 company reported payments to CMS in program years 2024–2024. These are public disclosures, not judgments. The latest:
- Janssen Research & Development, LLCProgram year20242 payments$78,000openpaymentsdata.cms.gov ↗
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
- Internal medicine training
Cleveland Clinic and Johns Hopkins
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗ - Fellowship
Clinical Genetics, Johns Hopkins
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗ - Fellowship
Hematology-Oncology, Massachusetts General Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗ - Board Certified
Internal Medicine and Medical Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →findatopdoc.com ↗
Editorial & leadership rolesjournal and society appointments
- Adjunct Professor of Medicine
Brown University (appointment renewed for 5-year term, announced March 2026); engages with hematology-oncology division and cancer center fellows/faculty on drug-development perspectives
2026verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →the-asci.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncxerna.com ↗
Secondary affiliationsappointments beyond the home institution
- Adjunct Professor of Medicine
Brown University
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →oncodaily.com ↗
- Guest
Biotech2050 Podcast, discussed genetics-informed precision medicine drug development
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- LinkedIn
linkedin.com/in/hagop-youssoufian-04b4896
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/hagop-youssoufian
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Other
oncodaily.com/career/163442
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncodaily.com ↗ - LinkedIn
LinkedIn: linkedin.com/in/hagop-youssoufian (Biotech Consultant, Adjunct Professor)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - X / Twitter
Twitter/X: @hyoussoufian
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Hagop Kantarjian, MD
The University of Texas MD Anderson Cancer Center
- 5,579
- publications
- 233
- h-index
- 24
- trials
Jorge Cortes, MD
Augusta University
- 3,575
- publications
- 180
- h-index
- 67
- trials
Ayalew Tefferi, MD
Mayo Clinic
- 2,093
- publications
- 154
- h-index
- 7
- trials
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
- 639
- publications
- 131
- h-index
- 4
- trials